The new induced pluripotent stem (iPS) cells, as they're dubbed, were created simply by identifying four genes that, when inserted into skin cells, reprogrammed the DNA. Then the iPS cells began reproducing steadily, which means that scientists should be able to produce an unlimited supply. The first task is to create cells carrying diseases to learn how to prevent and cure them. The ultimate goal is to use the cells to heal diseased and damaged organs.
The Japanese team, led by Shinya Yamanaka, demonstrated that with a little coaxing, the iPS cells, like embryonic stem cells, could transform themselves into different types of human tissue. First they manipulated a cluster to create nerve cells. Then they tried for heart cells. Just 12 days after mixing a sample of iPS cells with a cocktail of proteins in a petri dish, the scientists watched as clumps of newly formed cardiac cells started beating like a human heart. The iPS cells even have an advantage over embryonic: Since they're derived from the patient's own cells, there's no risk of rejection.
Amid the heady optimism unleashed by their discoveries, Thomson and Yamanaka caution that more work needs to be done before iPS cells can be put to widespread use. Until then, research on embryonic stem cells, and the controversy, will most likely continue. 5+ years


From



Advertisement 
































Your Comments
See all
...